IAN T. BOTHWELL - 13 May 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
13 May 2021
Net transactions value
-$42,492
Form type
4
Filing time
20 May 2021, 21:45:40 UTC
Previous filing
12 May 2021
Next filing
25 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $11,000 -50,000 -0.03% $0.2200 149,520,000 18 May 2021 Direct
transaction OCEL Common Stock Sale $12,000 -50,000 -0.03% $0.2400 149,470,000 19 May 2021 Direct
transaction OCEL Common Stock Sale $5,000 -25,000 -0.02% $0.2000 149,445,000 19 May 2021 Direct
transaction OCEL Common Stock Sale $9,500 -50,000 -0.03% $0.1900 149,395,000 20 May 2021 Direct
transaction OCEL Common Stock Sale $4,992 -26,274 -0.02% $0.1900 149,368,726 20 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.